Desmoplastic small round cell tumors: Multimodality treatment and new risk factors.

Monika ScheerChristian VokuhlBernd BlankErika HallmenThekla von KalleMarc MünterRüdiger WessalowskiMaite HartwigMonika Sparber-SauerPaul-Gerhardt SchlegelChristof M KrammUdo KontnyBernd SpriewaldThomas KegelSebastian BauerBernarda KazanowskaFelix NiggliRuth LadensteinGustaf LjungmanKirsi JahnukainenJörg FuchsStefan S BielackThomas KlingebielEwa Koscielniaknull null

Published in: Cancer medicine (2019)

Pleural effusions, venous thrombosis, and CRP elevation were identified as potential risk factors. The VAIA scheme showed best outcome. Maintenance therapy should be investigated further.

Keyphrases

risk factors
single cell
cell therapy
stem cells
risk assessment
human health
replacement therapy
mass spectrometry